Management of aBC patients post CDK4/6i
Management of aBC patients post CDK4/6i Featured Expert Panel: • Dr. Shaheenah Dawood (UAE) - Moderator • Dr. Javier Cortes (Spain) • Dr. Ahlam Mohammad (Qatar) • Dr. Mohammed Hourani (UAE) • Dr. Nouri Bennini (UAE) • Dr. Ramanujam Singarachari (UAE) • Dr. Sahar Awad (Oman)
▶︎
Updates on 2L Metastatic Breast Cancer Management for PIK3CA/AKT/PTEN Alteration
▶︎
Evolving Paradigms: The Role of Immunotherapy Across the Lung Cancer Spectrum
▶︎
ASCO 2026 Highlights Panel Discussion | Dana-Farber Cancer Institute
▶︎
Management of Patients with AKTm post CDK4/6i
▶︎
Sen. Whitehouse to uncover connections between Trump, Russia, and Epstein.
▶︎
Tufayl ibn Amr (ra): The Hidden Legend | The Firsts | Dr. Omar Suleiman
▶︎
7th BCOS 2026 Best Clinical Oncology Symposium || 26th June
▶︎
CDK4/6i: Post ASCO Updates
▶︎
Politics Chat, June 30, 2026
▶︎
Menarini Symposium: Strategic Treatment Sequencing and Novel Approaches in 2L+ ER+/HER2– mBC
▶︎
DIRECTO | Powell se somete al Congreso: ¿dará más pistas de la bajada de tipos?
▶︎
Beyond EGFR TKIs in the Management of Advanced or Metastatic EGFRm NSCLC
▶︎
KONTRA #27 Rymanowski, Bartosiak, Bosak: Co dalej z Ukrainą?
▶︎
Emerging Evidence in Endocrine Resistance and SERD-Based Strategies: Clinical Perspectives
▶︎
HR +ve/HER2 –ve Breast Cancer : Reflections from 2025
▶︎
This Common Food Is Feeding Your Cancer Cells - Dr. William Li
▶︎
Female-Specific Exercise & Nutrition for Health, Performance & Longevity | Dr. Stacy Sims
▶︎
From Advanced to Early Breast Cancer: CDK4/6i Overview
▶︎
Redefining Progression in ER+ve/HER2-ve aBC: Insights from Emerging Clinical Evidence
▶︎